Key result
Alimemazine improves psychosomatic symptoms and normalizes anxiety scores in comorbid cardiovascular disease.
Why the study?
Stress and anxiety worsen cardiovascular disease course and treatment response, highlighting the need to evaluate psychotropic therapies such as alimemazine in patients with comorbid psychopathology.
Does alimemazine improve anxiety and psychosomatic symptoms in a patient with hypertension and cardiac arrhythmias?
Case Report (n=1)
No
Does alimemazine improve anxiety and psychosomatic symptoms in a patient with hypertension and cardiac arrhythmias?
This case report suggests that identifying and treating comorbid psychological stress with a mild antipsychotic like alimemazine can substantially improve psychosomatic manifestations in patients with cardiovascular disease.
Hypothesis-generating for alimemazine in anxiety comorbid with hypertension and arrhythmias; controlled trials needed before adoption.
In the modern world, stress occupies a leading place among significant problems for humanity, being an etiological factor of about 80% of diseases. Social, physical and psychological factors can act as stressors that influence and determine the non-specific response of the body. In most cases, the nonspecific stress-induced reaction of the body is manifested by the picture of psychovegetative syndrome, an important component of which is the activation of the sympathetic nervous system. In a prolonged stress situation, psychovegetative syndrome can be a manifestation of stress-induced anxiety. Anxiety is detected in more than 25% of patients with a general somatic profile. Stress-induced reactions and anxiety can subsequently contribute to the development of psychogenic somatic pathology, including the cardiovascular pathology. Acute or chronic stress situation increases the risks of developing arterial hypertension, coronary heart disease, heart rhythm disorders. In the presence of background cardiac pathology, stress-induced reactions contribute to the deterioration of its course and reduce the effectiveness of treatment. The above indicates the need for a comprehensive assessment of the condition of patients with a general somatic profile. The active use in practical medicine of psychometric and psychodiagnostic scales for anxiety and depression is shown to assess the mental status of patients. When detecting stress-induced reactions or comorbid psychopathology, inclusion of psychotropic drugs, including antipsychotics (alimemazine), is indicated in the complex therapy. Timely administration of alimemazine in patients with a general somatic profile stops psychovegetative manifestations, has positive somatotropic effects due to the multimodal mechanism of action of the drug. In this clinical case, the use of alimemazine in a patient with hypertension, rhythm disorders and comorbid anxiety is presented.
No takes yet. Share an insight, caveat, or question.
Ebzeeva et al. (2023) conducted a case report in Arterial hypertension, cardiac arrhythmias, and generalized anxiety disorder (n=1). Alimemazine was evaluated on Improvement in anxiety scores and psychosomatic symptoms. Alimemazine at a dose of 15 mg per day successfully improved subjective psychosomatic symptoms and normalized objective anxiety scores in a 48-year-old female with hypertension, arrhythmias, and generalized anxiety disorder.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: